§ Federal grant opportunity · PAR-25-414
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
National Institutes of Health is accepting applications for Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed). The deadline is September 7, 2028 and the published award range is $100K.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- September 7, 2028
- Award range
- $100K
- Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
- Geography
- United States
- Focus areas
- Education, Environment, Food Security, Health, Human Services
- Opportunity number
- PAR-25-414
Program overview
The SuRE program supports research capacity building at eligible higher education institutions by funding investigator-initiated biomedical research inbasic, social, clinical, behavioral, or translational science that falls in the mission areas of the NIH. The purpose of SuRE awards is to provide support for investigator-initiated research at resource-limited institutions by full-time faculty who are not currently funded by any NIH Research Project Grants (RPGs) with the exception of SuRE or SuRE-First awards, to furnish students with high-quality undergraduate and/or graduate research experiences, and to enhance the institutional scientific research culture.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before September 7, 2028, allowing time for registration and validation.
Related grant opportunities
- NIGMS Institutional Biomedical Undergraduate Research Training (BURT) Program (T34)
- Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
- Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
- Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
- Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.